Company Information

Company R-Biopharm AG
r-biopharm.com
Type:
Company
Country:
Germany
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
28 June 2018
Letter of Commitment Letter of Re-commitment
Next Communication on Progress (COP) due on:
31 July 2025

Communication On Progress

Published On Title Level/Status
23-Sep-2019 Communication on Progress Active
28-Jun-2019 Grace Letter Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.